Literature DB >> 17595532

Infections with human rhinovirus induce the formation of distinct functional membrane domains.

Stephan Dreschers1, Peter Franz, Claudia Dumitru, Barbara Wilker, Klaus Jahnke, Erich Gulbins.   

Abstract

The plasma membrane contains distinct domains that are characterized by a high concentration of sphingolipids and cholesterol. These membrane microdomains also referred to as rafts, seem to be intimately involved in transmembranous signaling and often initiate interactions of pathogens and the host cell membranes. Here, we investigated the further reorganization of membrane rafts in cultured epithelial cells and ex vivo isolated nasal cells after infection with rhinoviruses. We demonstrate the formation of ceramide-enriched membrane platforms and large glycosphingolipid-enriched membrane domains and the co-localization of fluorochrome-labeled rhinoviruses with these membrane domains during attachment and uptake of human rhinovirus. Destruction of glycosphingolipid-enriched membrane domains blocked infection of human cells with rhinovirus. Furthermore, our studies indicate that the activation of the acid sphingomyelinase (ASM) is intrigued in the formation of ceramide- or GM1- enriched membrane platforms. Inhibition of the ASM reduces the number of ceramide-enriched platforms and glycosphingolipid-enriched membrane domains. These data reveal a critical role of the ASM for the formation of membrane platforms and infection of human cells with rhinoviruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595532     DOI: 10.1159/000104170

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

Review 1.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

Review 2.  Rhinoviruses and Their Receptors: Implications for Allergic Disease.

Authors:  Yury A Bochkov; James E Gern
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

Review 3.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

4.  Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress.

Authors:  Roger Cubí; Ana Candalija; Arturo Ortega; Carles Gil; José Aguilera
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

5.  Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus.

Authors:  Makoto Taniguchi; Takafumi Tasaki; Hideaki Ninomiya; Yoshibumi Ueda; Koh-Ichi Kuremoto; Susumu Mitsutake; Yasuyuki Igarashi; Toshiro Okazaki; Tsutomu Takegami
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 6.  Ceramide and Related Molecules in Viral Infections.

Authors:  Nadine Beckmann; Katrin Anne Becker
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

7.  Productive entry pathways of human rhinoviruses.

Authors:  Renate Fuchs; Dieter Blaas
Journal:  Adv Virol       Date:  2012-11-26

Review 8.  Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons.

Authors:  Nadine Beckmann; Deepa Sharma; Erich Gulbins; Katrin Anne Becker; Bärbel Edelmann
Journal:  Front Physiol       Date:  2014-09-02       Impact factor: 4.566

9.  Impairing the function of MLCK, myosin Va or myosin Vb disrupts Rhinovirus B14 replication.

Authors:  Antonio Real-Hohn; D William Provance; Rafael Braga Gonçalves; Caio Bidueira Denani; Andréa Cheble de Oliveira; Verônica P Salerno; Andre Marco Oliveira Gomes
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

Review 10.  The Many Facets of Sphingolipids in the Specific Phases of Acute Inflammatory Response.

Authors:  Sabine Grösch; Alice V Alessenko; Elisabetta Albi
Journal:  Mediators Inflamm       Date:  2018-02-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.